NSPR: Innovative carotid stent technology is set to disrupt a rapidly expanding U.S. vascular market
A novel carotid stent with a 20-micron mesh is driving superior clinical outcomes and rapid adoption in a $1 billion U.S. market, supported by strong trial results, recent CMS reimbursement, and robust funding. Regulatory approvals and a strategic commercial push position the company for significan…
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.